Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Zhimeng Yao, Hongmei Dong, Jianlin Zhu, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 10

Showing 10 citing articles:

Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease
Anna Onisiforou, Christiana Christodoulou, Eleni Zamba‐Papanicolaou, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Navigating Specific Targets of Breast Cancer Symptoms: An Innovative Computer-Simulated Intervention Analysis
Minyu Liang, Yichao Pan, Jingjing Cai, et al.
European Journal of Oncology Nursing (2024) Vol. 74, pp. 102708-102708
Closed Access | Times Cited: 6
Integrating Bulk and Single-Cell Transcriptomic Data to Identify Ferroptosis-Associated Inflammatory Gene in Alzheimer’s Disease
Huiqin Zhou, Yuting Peng, Xinhua Huo, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2105-2122
Open Access
PTPRO represses breast cancer lung metastasis by inhibiting the JAK2-YAP axis
Xiao Xiong, Jingfang Liu, Xiaotong Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model
Ignacio Silva-Llanes, Silvia Rodríguez-López, Pedro González-Naranjo, et al.
Brain Behavior and Immunity (2025)
Closed Access
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
Yu Zhou, Zhimeng Yao, Yusheng Lin, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 888-888
Open Access | Times Cited: 2
Diosmin alleviates doxorubicin-induced chemobrain in rats via inhibition of oxido-inflammation, apoptosis and modulation of autophagy
Mega O. Oyovwi, Falajiki Y. Faith, Ohwin P. Ejiro, et al.
Brain Disorders (2023) Vol. 13, pp. 100111-100111
Open Access | Times Cited: 4
PTPRO Inhibits LPS-induced Apoptosis in Alveolar Epithelial Cells
Xuemeng Li, Qianqian Xiong, Qing‐Qing Yang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 718, pp. 150083-150083
Closed Access
Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson’s disease
Shichuan Tan, Huizhong Chi, Wang Pin, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Neuroprotective effect of empagliflozin against doxorubicin-induced chemobrain in rats: interplay between SIRT-1/MuRF-1/PARP-1/NLRP3 signaling pathways and enhanced expression of miRNA-34a and LncRNA HOTAIR
Merihane M. Nasr, Sara A. Wahdan, Reem N. El‐Naga, et al.
NeuroToxicology (2024)
Closed Access
Page 1

Scroll to top